Amble vs Gala
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Gala
Best for compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwideStarting at $149/mo
Side-by-Side Comparison
| Feature | Amble | Gala |
|---|---|---|
| Overall Score | 7.4/10 | ✓7.8/10 |
| Starting Price | $179/mo | ✓$149/mo |
| Editorial Rating | 3.7 ★ /5 | ✓3.9 ★ /5 |
| Features | 3 features | ✓7 features |
| States Available | ✓50 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Gala
Pros
- ✓Compounded semaglutide and tirzepatide on a single platform at $179/month with all doses included on the yearly plan
- ✓Lower-priced microdosing tirzepatide tier at $149/month for patients who want a sub-therapeutic starting protocol
- ✓Brand-name Ozempic available alongside compounded options
- ✓Marketing site claims licensed providers in all 50 states with free shipping included
- ✓24/7 patient support and provider visit included; cancel anytime
- ✓LegitScript verification seal displayed on the marketing site
Cons
- ✗$179/month rate is contingent on a yearly subscription; the standalone monthly price is not publicly disclosed on the landing pages
- ✗Brand-name Ozempic at $1,299/month is materially higher than peers offering brand Ozempic (e.g., Found at $1,100/month)
- ✗Pharmacy partners are not publicly named — site references a 'wide network of pharmacies across all 50 states' without attribution, which is a material YMYL transparency gap
- ✗Wegovy oral pill is advertised as 'coming soon' — not yet a live offering
- ✗Per-state availability list is not enumerated on the marketing site; the all-50-states claim is gated behind the signup intake
Our Verdict
Gala edges out Amble with a higher overall score of 7.8/10 and is particularly strong for compounded GLP-1/GIP combo therapy on a yearly subscription with free shipping nationwide. Amble remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.